| |
MIC breakpoints (μg/ml)
|
|---|
| |
DIN
|
EUCAST
|
|---|
|
Drug
|
S
|
I
|
R
|
S
|
I
|
R
|
|---|
|
Enterobacteriaceae
| | | | | | |
|
pip./taz.
|
≤4
|
8-32
|
>32
|
≤8
|
16
|
>16
|
|
cefotaxime
|
≤2
|
4-8
|
>8
|
≤1
|
2
|
>2
|
|
imipenema
|
≤2
|
4
|
>4
|
≤2
|
4-8
|
>8
|
|
ciprofloxacin
|
≤1
|
2
|
>2
|
≤0.5
|
1
|
>1
|
|
gentamicin
|
≤1
|
2-4
|
>4
|
≤2
|
4
|
>4
|
|
Pseudomonas aeruginosa
| | | | | | |
|
piperacillin
|
≤4
|
8-32
|
>32
|
≤16
|
─
|
>16
|
|
ceftazidime
|
≤4
|
8-16
|
>16
|
≤8
|
─
|
>8
|
|
imipenem
|
≤2
|
4
|
>4
|
≤4
|
8
|
>8
|
|
meropenem
|
≤2
|
4-8
|
>8
|
≤2
|
4-8
|
>8
|
|
ciprofloxacin
|
≤1
|
2
|
>2
|
≤0.5
|
1
|
>1
|
|
gentamicin
|
≤1
|
2-4
|
>4
|
≤4
|
─
|
>4
|
|
Stenotrophomonas maltophilia
| | | | | | |
|
trim./sulfam.
|
≤16
|
32-64
|
>64
|
≤4
|
─
|
>4
|
|
Acinetobacter baumanii
| | | | | | |
|
imipenem
|
≤2
|
4
|
>4
|
≤2
|
4-8
|
>8
|
|
meropenem
|
≤2
|
4-8
|
>8
|
≤2
|
4-8
|
>8
|
|
ciprofloxacin
|
≤1
|
2
|
>2
|
≤1
|
─
|
>1
|
|
gentamicin
|
≤1
|
2-4
|
>4
|
≤4
|
─
|
>4
|
|
Enterococcus spp.
| | | | | | |
|
ampicillin
|
≤2
|
4-8
|
>8
|
≤4
|
8
|
>8
|
|
vancomycin
|
≤4
|
8
|
>8
|
≤4
|
─
|
>4
|
|
teicoplanin
|
─
|
─
|
─
|
≤2
|
─
|
>2
|
|
linezolid
|
─
|
─
|
─
|
≤4
|
─
|
>4
|
|
Staphylococcus spp.
| | | | | | |
|
oxacillinb
|
≤1
|
─
|
>1
|
≤2
|
─
|
>2
|
|
oxacillinc
|
≤1
|
─
|
>1
|
≤0.25
|
─
|
>0.25
|
|
vancomycinb
|
≤4
|
8
|
>8
|
≤2
|
─
|
>2
|
|
vancomycinc
|
≤4
|
8
|
>8
|
≤4
|
─
|
>4
|
|
teicoplaninb
|
─
|
─
|
─
|
≤2
|
─
|
>2
|
|
teicoplaninc
|
─
|
─
|
─
|
≤4
|
─
|
>4
|
|
linezolid
|
─
|
─
|
─
|
≤4
|
─
|
>4
|
|
rifampicin
|
─
|
─
|
─
|
≤0.06
|
─
|
>0.5
|
|
clindamycin
|
≤1
|
2-4
|
>4
|
≤0.25
|
0.5
|
>0.5
|
- aProteus, Morganella, and Providencia spp. were tested against meropenem, bbreakpoints for S. aureus, cbreakpoints for coagulase-negative staphylococci, “─” no data.
